Kodiak Sciences IncNASDAQ:KOD
- LAST PRICE2.3700
- TODAY'S CHANGE (%)0.0800 (3.4934%)
- Bid / Lots2.3700/ 5
- Ask / Lots2.3900/ 2
- Open / Previous Close2.3100 / 2.2900
- Day Range
- 52 Week Range
- Volume280,742
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | KOD |
|---|---|---|
| 09:32 ET | 8671 | 2.27 |
| 09:34 ET | 1055 | 2.28 |
| 09:36 ET | 700 | 2.26 |
| 09:38 ET | 600 | 2.26 |
| 09:39 ET | 10433 | 2.26 |
| 09:41 ET | 695 | 2.25 |
| 09:43 ET | 900 | 2.26 |
| 09:45 ET | 4620 | 2.3 |
| 09:48 ET | 400 | 2.3 |
| 09:50 ET | 700 | 2.33 |
| 09:52 ET | 6231 | 2.34 |
| 09:54 ET | 2021 | 2.37 |
| 09:56 ET | 2600 | 2.41 |
| 09:57 ET | 100 | 2.41 |
| 09:59 ET | 100 | 2.43 |
| 10:03 ET | 1300 | 2.42 |
| 10:06 ET | 721 | 2.41 |
| 10:08 ET | 100 | 2.41 |
| 10:10 ET | 1411 | 2.41 |
| 10:12 ET | 2700 | 2.4006 |
| 10:14 ET | 1400 | 2.39 |
| 10:15 ET | 400 | 2.39 |
| 10:17 ET | 500 | 2.38 |
| 10:19 ET | 300 | 2.4 |
| 10:21 ET | 200 | 2.38 |
| 10:24 ET | 500 | 2.385 |
| 10:26 ET | 500 | 2.38 |
| 10:28 ET | 1000 | 2.37 |
| 10:30 ET | 4296 | 2.34 |
| 10:32 ET | 518 | 2.34 |
| 10:33 ET | 520 | 2.35 |
| 10:35 ET | 2096 | 2.355 |
| 10:39 ET | 400 | 2.35 |
| 10:42 ET | 200 | 2.35 |
| 10:44 ET | 500 | 2.34 |
| 10:48 ET | 100 | 2.34 |
| 10:50 ET | 1521 | 2.355 |
| 10:51 ET | 200 | 2.355 |
| 10:55 ET | 1700 | 2.35 |
| 10:57 ET | 2069 | 2.35 |
| 11:00 ET | 100 | 2.35 |
| 11:02 ET | 1700 | 2.33 |
| 11:04 ET | 400 | 2.32 |
| 11:06 ET | 400 | 2.32 |
| 11:08 ET | 520 | 2.315 |
| 11:09 ET | 400 | 2.32 |
| 11:11 ET | 200 | 2.325 |
| 11:13 ET | 900 | 2.325 |
| 11:15 ET | 300 | 2.32 |
| 11:18 ET | 200 | 2.32 |
| 11:20 ET | 907 | 2.32 |
| 11:22 ET | 300 | 2.31 |
| 11:24 ET | 400 | 2.31 |
| 11:26 ET | 100 | 2.32 |
| 11:27 ET | 900 | 2.31 |
| 11:29 ET | 1130 | 2.3 |
| 11:31 ET | 800 | 2.29 |
| 11:33 ET | 300 | 2.295 |
| 11:36 ET | 200 | 2.295 |
| 11:38 ET | 300 | 2.29 |
| 11:40 ET | 300 | 2.28 |
| 11:42 ET | 100 | 2.29 |
| 11:44 ET | 1100 | 2.285 |
| 11:45 ET | 600 | 2.2898 |
| 11:47 ET | 1526 | 2.295 |
| 11:51 ET | 572 | 2.295 |
| 11:54 ET | 2550 | 2.315 |
| 11:56 ET | 400 | 2.32 |
| 11:58 ET | 200 | 2.33 |
| 12:00 ET | 100 | 2.34 |
| 12:03 ET | 100 | 2.34 |
| 12:05 ET | 38800 | 2.335 |
| 12:07 ET | 1300 | 2.34 |
| 12:09 ET | 2966 | 2.34 |
| 12:12 ET | 500 | 2.34 |
| 12:14 ET | 339 | 2.34 |
| 12:16 ET | 3750 | 2.34 |
| 12:18 ET | 299 | 2.34 |
| 12:20 ET | 21454 | 2.41 |
| 12:21 ET | 1100 | 2.41 |
| 12:23 ET | 654 | 2.42 |
| 12:30 ET | 100 | 2.43 |
| 12:32 ET | 838 | 2.425 |
| 12:34 ET | 800 | 2.42 |
| 12:36 ET | 718 | 2.42 |
| 12:38 ET | 276 | 2.41 |
| 12:39 ET | 2202 | 2.41 |
| 12:41 ET | 100 | 2.41 |
| 12:43 ET | 1500 | 2.405 |
| 12:45 ET | 200 | 2.405 |
| 12:48 ET | 854 | 2.41 |
| 12:50 ET | 100 | 2.415 |
| 12:52 ET | 200 | 2.41 |
| 12:54 ET | 405 | 2.41 |
| 12:56 ET | 100 | 2.41 |
| 12:57 ET | 1608 | 2.41 |
| 12:59 ET | 696 | 2.4 |
| 01:01 ET | 200 | 2.4 |
| 01:03 ET | 441 | 2.405 |
| 01:06 ET | 1192 | 2.4 |
| 01:08 ET | 200 | 2.4 |
| 01:10 ET | 1162 | 2.41 |
| 01:12 ET | 2051 | 2.42 |
| 01:14 ET | 1512 | 2.43 |
| 01:15 ET | 1312 | 2.43 |
| 01:17 ET | 830 | 2.43 |
| 01:19 ET | 450 | 2.43 |
| 01:21 ET | 1752 | 2.425 |
| 01:24 ET | 700 | 2.43 |
| 01:26 ET | 400 | 2.43 |
| 01:28 ET | 400 | 2.43 |
| 01:30 ET | 500 | 2.43 |
| 01:32 ET | 4346 | 2.41 |
| 01:33 ET | 200 | 2.405 |
| 01:35 ET | 100 | 2.405 |
| 01:37 ET | 1340 | 2.42 |
| 01:39 ET | 400 | 2.41 |
| 01:42 ET | 11120 | 2.415 |
| 01:44 ET | 646 | 2.42 |
| 01:46 ET | 300 | 2.42 |
| 01:48 ET | 1960 | 2.43 |
| 01:50 ET | 709 | 2.425 |
| 01:51 ET | 1300 | 2.425 |
| 01:53 ET | 500 | 2.43 |
| 01:55 ET | 600 | 2.43 |
| 01:57 ET | 16463 | 2.435 |
| 02:00 ET | 3400 | 2.445 |
| 02:02 ET | 16185 | 2.4 |
| 02:04 ET | 7850 | 2.38 |
| 02:08 ET | 300 | 2.37 |
May 29, 2024
Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences, from 4:36PM ET on Wednesday May 29, 2024 by Dow Jones
4:36PM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Kodiak Sciences Inc | 120.3M | -0.5x | --- |
Nuvectis Pharma Inc | 119.3M | -4.6x | --- |
Tevogen Bio Holdings Inc | 124.6M | -1,693.0x | --- |
DiaMedica Therapeutics Inc | 112.4M | -5.3x | --- |
Citius Pharmaceuticals Inc | 112.4M | -2.7x | --- |
Vicapsys Life Sciences Inc | 128.3M | -172.6x | --- |
Company Information
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Contact Information
- Headquarters
- 1200 PAGE MILL RDPALO ALTO, CA, United States 94304
- Phone
- 650-281-0850
- Fax
- 302-636-5454
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Victor Perlroth
- Chief Financial Officer, Executive Vice President, Secretary
- John Borgeson
- Lead Independent Director
- Robert Profusek
- Independent Director
- Felix Baker
- Independent Director
- Charles Bancroft
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $120.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.36 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
